Green Alpha Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562K | Sell |
50,016
-4,476
| -8% | -$50.3K | 0.54% | 60 |
|
|
2025
Q1 | $249K | Buy |
54,492
+25,054
| +85% | +$114K | 0.27% | 90 |
|
|
2024
Q4 | $166K | Buy |
29,438
+3,840
| +15% | +$21.7K | 0.13% | 131 |
|
|
2024
Q3 | $124K | Buy |
25,598
+6,165
| +32% | +$29.8K | 0.1% | 133 |
|
|
2024
Q2 | $94.8K | Sell |
19,433
-5,507
| -22% | -$26.9K | 0.08% | 132 |
|
|
2024
Q1 | $331K | Buy |
24,940
+2,574
| +12% | +$34.2K | 0.24% | 118 |
|
|
2023
Q4 | $312K | Sell |
22,366
-2,259
| -9% | -$31.5K | 0.22% | 130 |
|
|
2023
Q3 | $327K | Buy |
+24,625
| New | +$327K | 0.25% | 120 |
|